NO940595L - Cykliske derivater, legemidler som inneholder disse forbindelsene og fremgangsmåte ved deres fremstilling - Google Patents

Cykliske derivater, legemidler som inneholder disse forbindelsene og fremgangsmåte ved deres fremstilling

Info

Publication number: NO940595L
Authority: NO; Norway
Prior art keywords: compounds; preparation; drugs containing; cyclic derivatives; derivatives
Prior art date: 1993-02-22

Application number

NO940595A

Other languages

English (en)

Other versions

NO940595D0 (no

NO305081B1 (no

Inventor

Frank Himmelsbach

Helmut Pieper

Volkhard Austel

Gunther Linz

Brian Guth

Thomas Muller

Hans Weisenberger

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-22

Filing date

1994-02-21

Publication date

1994-08-23

1993-02-22 Priority claimed from DE4305388A external-priority patent/DE4305388A1/de

1994-02-21 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1994-02-21 Publication of NO940595D0 publication Critical patent/NO940595D0/no

1994-08-23 Publication of NO940595L publication Critical patent/NO940595L/no

1999-03-29 Publication of NO305081B1 publication Critical patent/NO305081B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Hydrogenated Pyridines (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO940595A 1993-02-22 1994-02-21 Cykliske derivater, legemidler som inneholder disse forbindelsene og fremgangsmÕte ved deres fremstilling NO305081B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4305388A DE4305388A1 (de)	1993-02-22	1993-02-22	Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4332168A DE4332168A1 (de)	1993-02-22	1993-09-22	Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (3)

Publication Number	Publication Date
NO940595D0 NO940595D0 (no)	1994-02-21
NO940595L true NO940595L (no)	1994-08-23
NO305081B1 NO305081B1 (no)	1999-03-29

Family

ID=25923309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO940595A NO305081B1 (no)	1993-02-22	1994-02-21	Cykliske derivater, legemidler som inneholder disse forbindelsene og fremgangsmÕte ved deres fremstilling

Country Status (22)

Country	Link
US (3)	US5519036A (no)
EP (1)	EP0612741B1 (no)
JP (1)	JP3545446B2 (no)
KR (1)	KR100322319B1 (no)
CN (1)	CN1048490C (no)
AT (1)	ATE167185T1 (no)
AU (1)	AU673875B2 (no)
CA (1)	CA2116068A1 (no)
CZ (1)	CZ37494A3 (no)
DE (2)	DE4332168A1 (no)
DK (1)	DK0612741T3 (no)
ES (1)	ES2118992T3 (no)
FI (1)	FI940806L (no)
HU (1)	HU222112B1 (no)
IL (1)	IL108733A (no)
MX (1)	MX9401315A (no)
NO (1)	NO305081B1 (no)
NZ (1)	NZ250944A (no)
PH (1)	PH30602A (no)
PL (1)	PL178215B1 (no)
SG (1)	SG52300A1 (no)
UA (1)	UA39099C2 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332168A1 (de) *	1993-02-22	1995-03-23	Thomae Gmbh Dr K	Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19624069A1 (de) *	1996-06-17	1997-12-18	Thomae Gmbh Dr K	Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5849736A (en) *	1993-11-24	1998-12-15	The Dupont Merck Pharmaceutical Company	Isoxazoline and isoxazole fibrinogen receptor antagonists
DE4424974A1 (de) *	1994-07-15	1996-01-18	Thomae Gmbh Dr K	Harnstoff- und Carbaminsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4427838A1 (de) *	1994-08-05	1996-02-08	Thomae Gmbh Dr K	Kondensierte Azepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4429079A1 (de) *	1994-08-17	1996-02-22	Thomae Gmbh Dr K	Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EE9700141A (et) *	1994-12-23	1997-12-15	Dr. Karl Thomae Gmbh	Piperasiinderivaadid, neid sisaldavad ravimid, nende kasutamine ja valmistamise meetod
ZA963391B (en) *	1995-05-24	1997-10-29	Du Pont Merck Pharma	Isoxazoline fibrinogen receptor antagonists.
US5925635A (en) *	1996-04-17	1999-07-20	Dupont Pharmaceuticals Company	N-(amidinophenyl) cyclourea analogs as factor XA inhibitors
IL123986A (en)	1997-04-24	2011-10-31	Organon Nv	Medicinal compounds
WO1999011658A1 (en)	1997-08-29	1999-03-11	Proteus Molecular Design Ltd.	Meta-benzamidine derivatives as serin protease inhibitors
US6340687B1 (en)	1997-09-03	2002-01-22	American Home Products Corporation	Substituted tetrahydro-pyrimidine-2(1H)-thione HDL-C elevators useful as antiatherosclerotic agents
AU753675B2 (en) *	1998-03-19	2002-10-24	Ajinomoto Co., Inc.	Aminoisoquinoline derivatives
AU3631500A (en) *	1999-03-19	2000-10-09	Du Pont Pharmaceuticals Company	N-adamant-1-yl-n'-(4-chlorobenzothiazol-2-yl) urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent
US6492406B1 (en) *	1999-05-21	2002-12-10	Astrazeneca Ab	Pharmaceutically active compounds
ATE410165T1 (de)	2001-04-18	2008-10-15	Euro Celtique Sa	Nociceptin-analoga
US7291603B2 (en)	2002-07-24	2007-11-06	Ptc Therapeutics, Inc.	Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
CA2495589A1 (en) *	2002-08-14	2004-02-26	Abbott Laboratories	Azabicyclic compounds are central nervous system active agents
US7135484B2 (en)	2002-08-14	2006-11-14	Abbott Laboratories	Azabicyclic compounds are central nervous system active agents
PT1572215E (pt)	2002-12-20	2009-12-09	Glaxo Group Ltd	Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
GB0405628D0 (en) *	2004-03-12	2004-04-21	Glaxo Group Ltd	Novel compounds
EP1621535A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1799684B1 (en) *	2004-10-04	2014-12-03	Millennium Pharmaceuticals, Inc.	Lactam compounds useful as protein kinase inhibitors
WO2006117657A1 (en) *	2005-05-03	2006-11-09	Ranbaxy Laboratories Limited	Triazolone derivatives as anti-inflammatory agents
ES2580108T3 (es)	2005-07-11	2016-08-19	Aerie Pharmaceuticals, Inc	Compuestos de isoquinolina
PE20080145A1 (es)	2006-03-21	2008-02-11	Janssen Pharmaceutica Nv	Tetrahidro-pirimidoazepinas como moduladores de trpv1
CA2655574A1 (en)	2006-06-20	2007-12-27	Wyeth	Imidazole kv1.5 potassium channel inhibitors
WO2008009125A1 (en) *	2006-07-20	2008-01-24	Cascade Therapeutics Inc.	Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
EP2526948A1 (en)	2006-09-20	2012-11-28	Aerie Pharmaceuticals, Inc.	RHO kinase inhibitors
US8455513B2 (en) *	2007-01-10	2013-06-04	Aerie Pharmaceuticals, Inc.	6-aminoisoquinoline compounds
JP5562865B2 (ja)	2007-12-17	2014-07-30	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｔｒｐｖ１のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター
WO2009079765A1 (en) *	2007-12-21	2009-07-02	Cascade Therapeutics Inc.	Compounds with activity at the 5-ht2c receptor
US8455514B2 (en) *	2008-01-17	2013-06-04	Aerie Pharmaceuticals, Inc.	6-and 7-amino isoquinoline compounds and methods for making and using the same
US8450344B2 (en)	2008-07-25	2013-05-28	Aerie Pharmaceuticals, Inc.	Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US7998952B2 (en)	2008-12-05	2011-08-16	Millennium Pharmaceuticals, Inc.	Thiolactams and uses thereof
WO2010126626A2 (en)	2009-05-01	2010-11-04	Aerie Pharmaceuticals, Inc.	Dual mechanism inhibitors for the treatment of disease
PE20121048A1 (es) *	2009-06-26	2012-08-25	Novartis Ag	Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
MX359399B (es)	2011-04-28	2018-09-27	Novartis Ag	Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
ES2776199T3 (es)	2013-03-15	2020-07-29	Aerie Pharmaceuticals Inc	Conjugados de compuestos de isoquinolina y prostaglandinas
US9643927B1 (en)	2015-11-17	2017-05-09	Aerie Pharmaceuticals, Inc.	Process for the preparation of kinase inhibitors and intermediates thereof
WO2017086941A1 (en)	2015-11-17	2017-05-26	Aerie Pharmaceuticals, Inc.	Process for the preparation of kinase inhibitors and intermediates thereof
WO2018045091A1 (en)	2016-08-31	2018-03-08	Aerie Pharmaceuticals, Inc.	Ophthalmic compositions
CA3057872A1 (en)	2017-03-31	2018-10-04	Aerie Pharmaceuticals, Inc.	Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AU2019337703B2 (en)	2018-09-14	2023-02-02	Aerie Pharmaceuticals, Inc.	Aryl cyclopropyl-amino-isoquinolinyl amide compounds
EP4352062A4 (en) *	2021-05-05	2025-05-14	Diamond Therapeutics Inc.	5-HT2A AND/OR 5-HT2C RECEPTOR AGONISTS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9106571D0 (en) *	1991-03-27	1991-05-15	Erba Carlo Spa	Derivatives of substituted imidazol-2-one and process for their preparation
DE4107857A1 (de) *	1991-03-12	1992-09-17	Thomae Gmbh Dr K	Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4112014A1 (de) *	1991-04-12	1992-10-15	Thomae Gmbh Dr K	Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
DE4127404A1 (de) *	1991-08-19	1993-02-25	Thomae Gmbh Dr K	Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4332168A1 (de) *	1993-02-22	1995-03-23	Thomae Gmbh Dr K	Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AU675484B2 (en) *	1993-03-24	1997-02-06	Neurosearch A/S	Benzimidazole compounds, their use and preparation

1993
- 1993-09-22 DE DE4332168A patent/DE4332168A1/de not_active Ceased
1994
- 1994-02-21 PL PL94302302A patent/PL178215B1/pl unknown
- 1994-02-21 AT AT94102557T patent/ATE167185T1/de not_active IP Right Cessation
- 1994-02-21 MX MX9401315A patent/MX9401315A/es unknown
- 1994-02-21 NO NO940595A patent/NO305081B1/no not_active IP Right Cessation
- 1994-02-21 PH PH47791A patent/PH30602A/en unknown
- 1994-02-21 EP EP94102557A patent/EP0612741B1/de not_active Expired - Lifetime
- 1994-02-21 HU HU9400493A patent/HU222112B1/hu not_active IP Right Cessation
- 1994-02-21 SG SG1996002477A patent/SG52300A1/en unknown
- 1994-02-21 KR KR1019940003193A patent/KR100322319B1/ko not_active Expired - Fee Related
- 1994-02-21 FI FI940806A patent/FI940806L/fi unknown
- 1994-02-21 UA UA94005097A patent/UA39099C2/uk unknown
- 1994-02-21 CA CA002116068A patent/CA2116068A1/en not_active Abandoned
- 1994-02-21 ES ES94102557T patent/ES2118992T3/es not_active Expired - Lifetime
- 1994-02-21 AU AU56324/94A patent/AU673875B2/en not_active Ceased
- 1994-02-21 DE DE59406157T patent/DE59406157D1/de not_active Expired - Fee Related
- 1994-02-21 JP JP02272794A patent/JP3545446B2/ja not_active Expired - Fee Related
- 1994-02-21 DK DK94102557T patent/DK0612741T3/da active
- 1994-02-21 CZ CZ94374A patent/CZ37494A3/cs unknown
- 1994-02-22 IL IL108733A patent/IL108733A/en not_active IP Right Cessation
- 1994-02-22 US US08/200,125 patent/US5519036A/en not_active Expired - Lifetime
- 1994-02-22 NZ NZ250944A patent/NZ250944A/en unknown
- 1994-02-22 CN CN94102252A patent/CN1048490C/zh not_active Expired - Fee Related
1995
- 1995-05-02 US US08/434,136 patent/US5612335A/en not_active Expired - Lifetime
1996
- 1996-12-17 US US08/768,365 patent/US5827849A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
HU9400493D0 (en)	1994-05-30
AU673875B2 (en)	1996-11-28
NO940595D0 (no)	1994-02-21
KR940019704A (ko)	1994-09-14
DK0612741T3 (da)	1999-03-29
EP0612741B1 (de)	1998-06-10
IL108733A (en)	1998-01-04
US5612335A (en)	1997-03-18
MX9401315A (es)	1994-08-31
IL108733A0 (en)	1994-05-30
CZ37494A3 (en)	1994-12-15
PL178215B1 (pl)	2000-03-31
NZ250944A (en)	1996-02-27
ATE167185T1 (de)	1998-06-15
HUT70768A (en)	1995-10-30
DE59406157D1 (de)	1998-07-16
CN1099755A (zh)	1995-03-08
JP3545446B2 (ja)	2004-07-21
JPH06256343A (ja)	1994-09-13
SG52300A1 (en)	1998-09-28
DE4332168A1 (de)	1995-03-23
US5827849A (en)	1998-10-27
ES2118992T3 (es)	1998-10-01
US5519036A (en)	1996-05-21
CN1048490C (zh)	2000-01-19
PH30602A (en)	1997-07-31
CA2116068A1 (en)	1994-08-23
FI940806A7 (fi)	1994-08-23
FI940806L (fi)	1994-08-23
AU5632494A (en)	1994-08-25
UA39099C2 (uk)	2001-06-15
HU222112B1 (hu)	2003-04-28
FI940806A0 (fi)	1994-02-21
KR100322319B1 (ko)	2002-06-26
NO305081B1 (no)	1999-03-29
EP0612741A1 (de)	1994-08-31

Legal Events

Date	Code	Title	Description
2003-09-29	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN AUGUST 2003

Publication	Publication Date	Title
NO940595D0 (no)	1994-02-21	Cykliske derivater, legemidler som inneholder disse forbindelsene og fremgangsmåte ved deres fremstilling
DK0624595T3 (da)	1999-05-17	Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
NO941680D0 (no)	1994-05-06	Monomere gallesyrederivater, fremgangsmåte for fremstilling av dem og deres anvendelse som legemiddel
DK0624596T3 (da)	1998-10-07	Tetrazolderivater af galdesyrer, fremgangsmåde tilderes fremstilling og anvendelse af disse forbindelser som lægemidler
DK0573848T3 (da)	1998-08-10	Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
DK0513543T3 (da)	1996-02-26	Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
BR9307451A (pt)	1999-08-31	Composto, composição farmacêutica e processo para fabricação de composto
DK0530087T3 (da)	1995-10-02	Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
AU630766B2 (en)	1992-11-05	Immunostimulating 6-aryl-5,6-dihydroimidazo(2,1-b) thiazole derivatives
DK0632026T3 (da)	1998-07-27	Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
DK0461986T3 (da)	1996-05-28	Hexahydroazepinderivater, en fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse
DK0564358T3 (da)	1999-07-19	3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
JPS6416791A (en)	1989-01-20	Guanidine related compound containing substituted tetraphenylborate ion and its production
FI913658A0 (fi)	1991-07-31	4-amino-d4,6-steroider och deras anvaendning som 5a-reduktas-inhibitorer.
NO301826B1 (no)	1997-12-15	Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler
DK0658557T3 (da)	1999-05-31	Eburnan-derivater, fremgangsmåde til fremstilling af sådanne derivater og farmaceutiske sammensætninger indeholdende disse
DK0612763T3 (da)	1997-12-15	Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK11089A (da)	1989-07-14	2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
DK0635491T3 (da)	1997-11-03	(Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser.
DK0627430T3 (da)	1997-06-02	Fremgangsmåde til omdannelse af loracarbef-dihydrat til loracarbefmonohydrat
AU579997B2 (en)	1988-12-22	Iminosulphonamides and processes for the manufacture thereof, pharmaceutical preparations containing such compounds, and their use
NO305556B1 (no)	1999-06-21	Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
DK656889A (da)	1990-06-24	Azabicykliske derivater
DK1098901T3 (da)	2003-05-05	Nye 6-deoxyerythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO20010244L (no)	2001-01-15	Medikamenter inneholdende polyhydroksyalkylpyrazinderivater, deres fremstilling samt medikamenter inneholdende derivatene